|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.730 USD | +13.03% |
|
+24.75% | +1.91% |
| 05-15 | Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Journey Medical Corporation secures contract with third major GPO for Emrosi | RE |
| Market Cap | 110M 95.96M 88.7M 81.84M 154M 10.54B 157M 1.06B 415M 5.15B 412M 403M 17.78B | P/E 2026 * |
1.38x | P/E 2027 * | -6.6x |
|---|---|---|---|---|---|
| Enterprise Value | 110M 95.96M 88.7M 81.84M 154M 10.54B 157M 1.06B 415M 5.15B 412M 403M 17.78B | EV / Sales 2026 * |
1.37x | EV / Sales 2027 * | 0.89x |
| Free-Float |
77.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Fortress Biotech, Inc.
| 1 day | +13.03% | ||
| 1 week | +24.75% | ||
| Current month | +21.90% | ||
| 1 month | +34.66% | ||
| 3 months | +54.13% | ||
| 6 months | +13.72% | ||
| Current year | +1.91% |
| 1 week | 3.02 |  | 3.75 |
| 1 month | 2.7 | | 3.75 |
| Current year | 2.18 | | 4.53 |
| 1 year | 1.77 | | 4.53 |
| 3 years | 1.24 | | 10.35 |
| 5 years | 1.24 | | 57.15 |
| 10 years | 1.24 | | 91.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 20/12/2013 | |
Xiao Qin Lu
DFI | Director of Finance/CFO | 51 | 22/02/2012 |
David Jin
DFI | Director of Finance/CFO | 36 | 16/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jimmie Harvey
BRD | Director/Board Member | 74 | 01/12/2008 |
| Chairman | 71 | 20/12/2013 | |
J. Lobell
BRD | Director/Board Member | 63 | 01/06/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-22 | Free | Chief Financial Officer | 400,000 | 1.2041% | ||
| 04-01 | Free | Chief Financial Officer | 2,967 | 0.0096% | ||
| 03-18 | Free | Chief Executive Officer | 475,424 | 1.5318% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +13.03% | +24.75% | +90.31% | -51.72% | 110M | |
| -1.05% | -2.97% | +14.99% | -8.68% | 67.46B | |
| -1.32% | -8.39% | +34.74% | +193.12% | 51.13B | |
| -2.29% | +36.80% | +36.80% | +36.80% | 43.4B | |
| +1.34% | -0.81% | -49.11% | -52.89% | 40.32B | |
| -8.17% | -6.68% | +44.20% | -31.18% | 30.86B | |
| +0.64% | -15.46% | +105.17% | -44.43% | 26.59B | |
| +0.57% | -2.69% | +64.16% | +86.01% | 22.82B | |
| +1.07% | +3.27% | +9.82% | +177.50% | 19.79B | |
| -1.56% | -5.38% | +53.69% | +123.21% | 16.47B | |
| Average | +0.13% | -1.89% | +40.48% | +42.77% | 31.9B | |
| Weighted average by Cap. | -1.36% | -2.78% | +28.59% | +44.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 79.88M 69.92M 64.63M 59.63M 112M 7.68B 114M 772M 302M 3.75B 300M 293M 12.95B | 123M 108M 99.52M 91.82M 173M 11.83B 176M 1.19B 465M 5.78B 462M 452M 19.95B |
| Net income | 90.51M 79.23M 73.24M 67.57M 127M 8.71B 130M 874M 343M 4.25B 340M 332M 14.68B | -20.84M -18.24M -16.86M -15.56M -29.29M -2B -29.87M -201M -78.85M -980M -78.27M -76.53M -3.38B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/07/26 | US$3.730 | +13.03% | 1,241,511 |
| 13/07/26 | US$3.300 | 0.00% | 863,059 |
| 10/07/26 | US$3.300 | +0.30% | 662,568 |
| 09/07/26 | US$3.290 | +9.67% | 1,085,209 |
| 08/07/26 | US$3.000 | +0.33% | 411,261 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FBIO Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
